Tobramycin Injection, Powder, Lyophilized, For Solution
Product Images NDC 70700-173
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 70700-173). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xiromed Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Tobramycin-carton-label (Tobramycin Carton Label)
This is a description of Tobramycin for Injection, USP. It is a pharmacy bulk package and not intended for direct infusion. It is used for intravenous use and contains no preservative. The usual dosage is not specified as this pharmacy bulk package is intended for preparing admixtures only. The product should be stored between 1 and 25°C prior to reconstitution. After reconstitution, it should be stored in a refrigerator and used within 96 hours. The container closure is not made with natural rubber latex. The manufacturer is Xiromed, LLC located in Florham Park, NJ.*
Tobramycin-container-label (Tobramycin Container Label)
This is the label of a Pharmacy Bulk Package of Tobramycin for Injection, USP from India. The Code Number is AP/DRUGS/103/97, and it should be discarded after a certain date which is not mentioned. The product is not for direct infusion and is intended for intravenous use only. The label contains some unclear text, as it was obtained by .*
Tobramycin-nomogram (Tobramycin Nomogram)
Tobramycin-structure (Tobramycin Structure)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.